Compare Stocks

→ A new way to collect income from stocks (From DTI) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EVFM Evofem Biosciences	$0.02 +19.7%	$0.02	$0.01 ▼ $3.75	$943K	-1.12	776,850 shs	401,085 shs
GERN Geron	$3.80 +6.7%	$2.83	$1.64 ▼ $4.05	$2.08B	0.62	11.02 million shs	3.92 million shs
MNK Mallinckrodt	$0.12	$0.34	$0.75 ▼ $6.42	$1.58M	N/A	2.62 million shs	39,227 shs
NEPT Neptune Wellness Solutions		$0.39	$0.19 ▼ $28.00	$906K	2.19	462,687 shs	2.25 million shs
OSMT Osmotica Pharmaceuticals		$1.16	$0.98 ▼ $4.95	$69.47M	2.34	396,682 shs	296,500 shs

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EVFM Evofem Biosciences	-4.70%	+0.71%	-21.98%	-59.31%	-99.44%
GERN Geron	-0.56%	-4.56%	+7.88%	+64.81%	+46.50%
MNK Mallinckrodt	0.00%	0.00%	0.00%	0.00%	-97.89%
NEPT Neptune Wellness Solutions	0.00%	0.00%	0.00%	-55.36%	-99.22%
OSMT Osmotica Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%

What is the 72-Hour Profit Surge? (Ad)

One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…

Click here now to get all the details.

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
EVFM Evofem Biosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GERN Geron	2.9427 of 5 stars	3.5	1.0	0.0	1.3	1.8	1.7	0.6
MNK Mallinckrodt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EVFM Evofem Biosciences	2.00	Hold	N/A	N/A
GERN Geron	3.00	Buy	$5.33	40.35% Upside
MNK Mallinckrodt	N/A	N/A	N/A	N/A
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest EVFM, NEPT, OSMT, GERN, and MNK Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/11/2024	GERN Geron	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$5.00
4/10/2024	GERN Geron	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$6.00
3/15/2024	GERN Geron	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform	$6.00
3/15/2024	GERN Geron	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$4.00 ➝ $5.00
3/15/2024	GERN Geron	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$4.00 ➝ $5.00
2/28/2024	GERN Geron	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$4.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EVFM Evofem Biosciences	$18.22M	0.05	$1.70 per share	0.01	($2.64) per share	-0.01
GERN Geron	$240K	8,658.78	N/A	N/A	$0.46 per share	8.26
MNK Mallinckrodt	N/A	N/A	N/A	N/A	$47.48 per share	N/A
NEPT Neptune Wellness Solutions	$52.62M	0.00	N/A	N/A	($91.90) per share	0.00
OSMT Osmotica Pharmaceuticals	$177.88M	0.00	N/A	1.00	$1.50 per share	0.00

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EVFM Evofem Biosciences	$52.98M	-$7.62	N/A	∞	N/A	290.81%	-90.20%	331.20%	4/26/2024 (Estimated)
GERN Geron	-$184.13M	-$0.33	N/A	N/A	N/A	-77,691.14%	-63.33%	-44.71%	5/2/2024 (Confirmed)
MNK Mallinckrodt	N/A	-$116.19	N/A	∞	N/A	-82.59%	20.32%	2.49%	N/A
NEPT Neptune Wellness Solutions	-$60.46M	-$106.72	N/A	N/A	N/A	-128.13%	N/A	-141.94%	7/15/2024 (Estimated)
OSMT Osmotica Pharmaceuticals	-$79.59M	-$1.59	N/A	N/A	N/A	-138.76%	-81.23%	-20.97%	N/A

Latest EVFM, NEPT, OSMT, GERN, and MNK Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/2/2024	N/A	GERN Geron	-$0.10	N/A	+$0.10	N/A	N/A	N/A
3/27/2024	Q4 2023	EVFM Evofem Biosciences	N/A	-$0.44	-$0.44	-$0.44	N/A	$4.84 million
2/28/2024	Q4 23	GERN Geron	-$0.10	-$0.09	+$0.01	-$0.09	$0.06 million	$0.02 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
EVFM Evofem Biosciences	N/A	N/A	N/A	N/A	N/A
GERN Geron	N/A	N/A	N/A	N/A	N/A
MNK Mallinckrodt	N/A	N/A	N/A	N/A	N/A
NEPT Neptune Wellness Solutions	N/A	N/A	N/A	N/A	N/A
OSMT Osmotica Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EVFM Evofem Biosciences	N/A	0.13	0.10
GERN Geron	0.14	3.16	3.16
MNK Mallinckrodt	1.18	0.57	0.31
NEPT Neptune Wellness Solutions	N/A	0.23	0.10
OSMT Osmotica Pharmaceuticals	N/A	0.43	0.42

Ownership

Institutional Ownership

Company	Institutional Ownership
EVFM Evofem Biosciences	0.22%
GERN Geron	73.71%
MNK Mallinckrodt	83.74%
NEPT Neptune Wellness Solutions	14.44%
OSMT Osmotica Pharmaceuticals	46.18%

Insider Ownership

Company	Insider Ownership
EVFM Evofem Biosciences	0.21%
GERN Geron	3.10%
MNK Mallinckrodt	0.30%
NEPT Neptune Wellness Solutions	5.10%
OSMT Osmotica Pharmaceuticals	5.22%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
EVFM Evofem Biosciences	37	55.46 million	53.85 million	Not Optionable
GERN Geron	141	546.87 million	529.92 million	Optionable
MNK Mallinckrodt	2,700	13.17 million	13.13 million	Not Optionable
NEPT Neptune Wellness Solutions	58	4.53 million	4.30 million	Not Optionable
OSMT Osmotica Pharmaceuticals	302	62.59 million	59.32 million	Not Optionable

EVFM, NEPT, OSMT, GERN, and MNK Headlines

Source	Headline
	Vanda Pharmaceuticals Inc. wsj.com - March 6 at 4:32 PM
	RVL Pharmaceuticals PLC (RVLPQ) investing.com - December 19 at 9:08 AM
	Other OTC Pharmaceuticals - Seychelles statista.com - October 8 at 8:51 PM
	Osmotica Pharmaceuticals is about to announce its earnings — here's what to expect markets.businessinsider.com - August 14 at 1:21 AM
	What Wall Street expects from Osmotica Pharmaceuticals's earnings markets.businessinsider.com - March 19 at 12:43 PM
	GRO Biosciences Appoints Rakhshita Dhar to its Board of Directors nz.finance.yahoo.com - January 19 at 9:21 PM
	UPDATE – Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance finance.yahoo.com - January 19 at 3:55 PM
	Osmotica Pharmaceuticals Announces Corporate Name Change to RVL Pharmaceuticals plc With New Ticker Symbol 'RVLP' benzinga.com - January 19 at 10:54 AM
	Osmotica Pharmaceuticals plc Announces Corporate Name Change to RVL Pharmaceuticals plc, New Ticker Symbol “RVLP,” Plans to Launch UPNEEQ® into the Medical Aesthetics Market, and Provides Fourth Quarter 2022 Net Sales Guidance finance.yahoo.com - January 19 at 10:54 AM
	RVL Pharmaceuticals to Host UPNEEQ® Overview and Business Update Webcast on January 19, 2022 finance.yahoo.com - January 18 at 7:56 AM
	Fresh Insights On Osmotica Pharmaceuticals plc (OSMT) stocksregister.com - January 15 at 6:25 PM
	Osmotica Pharmaceuticals plc (OSMT): What Is Good About Stock? marketingsentinel.com - January 11 at 7:36 AM
	Osmotica Pharmaceuticals plc to Host UPNEEQ® Overview and Business Update Call on January 19, 2022 finance.yahoo.com - January 6 at 9:24 AM
	Boom Or Bust: What Are Osmotica Pharmaceuticals plc’s (NASDAQ:OSMT) Future Prospects? marketingsentinel.com - January 1 at 10:28 AM
	Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Shares Rose Recently. However, Trouble May Still Be Lurking. stocksregister.com - December 27 at 12:57 PM
	Osmotica Pharmaceuticals plc (NASDAQ: OSMT): Why Investors Shouldn’t Ditch OSMT Stock In 2021 marketingsentinel.com - December 27 at 12:57 PM
	Osmotica Pharmaceuticals plc (NASDAQ:OSMT) Shares Plunged 0.00% In A Week – But Will They Keep Going Up? marketingsentinel.com - December 23 at 2:40 PM
	James Schaub Is The Executive VP & COO of Osmotica Pharmaceuticals plc (NASDAQ:OSMT) And They Just Picked Up 30% More Shares nasdaq.com - December 22 at 2:02 PM
	Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Bioconnect Conference finance.yahoo.com - December 20 at 6:40 PM
	Osmotica Pharmaceuticals plc (NASDAQ: OSMT):The Stock Was Down -2.04 Percent From Its Lows On Friday, So What’s To Come? marketingsentinel.com - December 18 at 6:32 PM
	Osmotica Pharmaceuticals EPS Diluted (5 Year Growth) ycharts.com - December 18 at 12:57 AM
	Osmotica Pharmaceuticals plc (OSMT) Could Be Sitting On A Goldmine stocksregister.com - December 4 at 10:20 AM
	What Analysts Were Expecting After Osmotica Pharmaceuticals plc (NASDAQ: OSMT) rose 2.76% stocksregister.com - November 25 at 2:06 PM
	The Future Of Osmotica Pharmaceuticals plc (NASDAQ: OSMT) In 2021 stocksregister.com - November 18 at 9:51 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Evofem Biosciences

NASDAQ:EVFM

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis. Evofem Biosciences, Inc. is headquartered in San Diego, California.

Geron

NASDAQ:GERN

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Mallinckrodt

NYSE:MNK

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.

Neptune Wellness Solutions

NASDAQ:NEPT

Neptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada.

Osmotica Pharmaceuticals

NASDAQ:OSMT

Osmotica Pharmaceuticals Plc engages in the development and commercialization of products for neurology and women's health. Its products include Upneeq, M-72, Arbaclofen ER, OS870, Divigel, OB Complete, Methylphenidate ER, Venlafaxine ER tablets (VERT), Hydromorphone ER, Sodium Benzoate/Sodium Phenylacetate, Oxybutynin ER, Prescription Prenatal Vitamins, Chlorzoxazone (Lorzone AG), Tramadol ER (ConZip AG), Nitrofurantoin and Osmodex ANDAs. The company was founded in 1986 and is headquartered in Bridgewater, NJ.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial